Eco Animal Health (GB:EAH) has released an update.
ECO Animal Health Group, a leading global animal health company, announced that an investor presentation on their full year results ending 31 March 2024 will be conducted online by CEO David Hallas and CFO Christopher Wilks on 16 July. The company, known for its veterinary pharmaceuticals and R&D pipeline, boasts a strong presence in over 70 countries and a flagship product, Aivlosin®, for treating livestock diseases. The event is accessible to all interested parties, with a recorded video available post-event.
For further insights into GB:EAH stock, check out TipRanks’ Stock Analysis page.
